Page 104 - Программа - Всероссийский конгресс с международным участием «Нейронауки: интеграция теории и практики», 18-19 ноября 2022 года, Онлайн

Известия Российской
НАУЧНЫЕ ОБЗОРЫ Том 41, № 4, 2022 Военно-медицинской академии
453
22. Song E, Bartley CM, Chow RD, et al. Divergent and self- 33. Ramanathan S, Mohammad S, Tantsis E, et al. Clinical course,
reactive immune responses in the CNS of COVID-19 patients therapeutic responses and outcomes in relapsing MOG anti-
with neurological symptoms. Cell Rep Med. 2021;2(5):100288. body-associated demyelination. J Neurol Neurosurg Psychiatry.
DOI: 10.1016/j.xcrm.2021.100288 2018;89(2):127–137. DOI: 10.1136/jnnp-2017-316880
23. Xiao M, Zhang Y, Zhang S, et al. Antiphospholipid Antibod- 34. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider
ies in Critically Ill Patients With COVID-19. Arthritis Rheumatol. cytokine storm syndromes and immunosuppression. Lancet.
2020;72(12):1998–2004. DOI: 10.1002/art.41425 2020;395(10229):1033–1034. DOI: 10.1016/s0140-6736(20)30628-0
24. Bertin D, Brodovitch A, Beziane A, et al. Anticardiolipin IgG Auto- 35. Lambe J, McGinley MP, Moss BP, et al. Myelin oligodendrocyte
antibody Level Is an Independent Risk Factor for COVID-19 Severity. glycoprotein-IgG associated disorders (MOGAD) following SARS-
Arthritis Rheumatol. 2020;72(11):1953–1955. DOI: 10.1002/art.41409 CoV-2 infection: A case series. J Neuroimmunol. 2022;370:577933.
25. Wang EY, Mao T, Klein J, et al. Diverse Functional Autoantibod- DOI: 10.1016/j.jneuroim.2022.577933
ies in Patients with COVID-19. Nature. 2021;595(7866):283–288. 36. Colantonio MA, Nwafor DC, Jaiswal S, et al. Myelin oligodendro-
DOI: 10.1101/2020.12.10.20247205 cyte glycoprotein antibody-associated optic neuritis and myelitis in
26. Woodruff MC, Ramonell RP, Nguyen DC, et al. Extrafol- COVID-19: a case report and a review of the literature. Egypt J Neurol
licular B cell responses correlate with neutralizing antibodies and Psychiatr Neurosurg. 2022;58(1):62. DOI: 10.1186/s41983-022-00496-4
morbidity in COVID-19. Nat Immunol. 2020;21(12):1506–1516.
DOI: 10.1038/s41590-020-00814-z 37. Mariotto S, Carta S, Dinoto A, et al. Is there a correlation between
27. Jenks SA, Cashman KS, Zumaquero E, et al. Distinct Effector MOG-associated disorder and SARS-CoV-2 infection? Eur J Neurol.
B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to 2022;29(6):1855–1858. DOI: 10.1111/ene.15304
Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 38. Marignier R, Hacohen Y, Cobo-Calvo A, et al. Myelin-oligoden-
2018;49(4):725–739.e6. DOI: 10.1016/j.immuni.2018.08.015. Erratum drocyte glycoprotein antibody-associated disease. Lancet Neurol.
in: Immunity. 2020;52(1):203. DOI: 10.1016/j.immuni.2019.12.005 2021;20(9):762–772. Erratum in: Lancet Neurol. 2021;20(10):e6.
28. Latorre D. Autoimmunity and SARS-CoV-2 infection: Unravel- Erratum in: Lancet Neurol. 2022;21(1):e1. PMID: 34418402.
ing the link in neurological disorders. Eur J Immunol. 2022;52(10): DOI: 10.1016/s1474-4422(21)00218-0
1561–1571. DOI: 10.1002/eji.202149475 39. Yi MH, Lee YS, Kang JW, et al. NFAT5-dependent expression
29. Garg RK, Paliwal VK, Gupta A. Spinal cord involvement of AQP4 in astrocytes. Cell Mol Neurobiol. 2013;33(2):223–232.
in COVID-19: A review. J Spinal Cord Med. 2021;11:1–15. DOI: 10.1007/s10571-012-9889-0
DOI: 10.1080/10790268.2021.1888022 40. Carnero Contentti E, Correale J. Neuromyelitis optica spectrum
30. West TW, Hess C, Cree BA. Acute transverse myelitis: demy- disorders: from pathophysiology to therapeutic strategies. J Neu-
elinating, inflammatory, and infectious myelopathies. Semin Neurol. roinflammation. 2021;18(1):208. DOI: 10.1186/s12974-021-02249-1
2012;32(2):97–113. DOI: 10.1055/s-0032-1322586 41. Machado C, Amorim J, Rocha J, et al. Neuromyelitis optica
31. Román GC, Gracia F, Torres A, et al. Acute Transverse Myeli- spectrum disorder and varicella-zoster infection. J Neurol Sci.
tis (ATM): Clinical Review of 43 Patients With COVID-19-Associ- 2015;358(1Pt 2):520–521. DOI: 10.1016/j.jns.2015.09.374
ated ATM and 3 Post-Vaccination ATM Serious Adverse Events 42. Harris MK, Maghzi AH, Etemadifar M, et al. Acute demyelinating
With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. disorders of the central nervous system. Curr Treat Options Neurol.
2021;12:653786. DOI: 10.3389/fimmu.2021.653786 2009;11(1):55–63. DOI: 10.1007/s11940-009-0008-6
32. Kozlova AO, Eliseeva DD, Simaniv TO, et al. Autoimmune spinal 43. Mirmosayyeb O, Ghaffary EM, Bagherieh S, et al. Post
cord lesions associated with novel coronavirus infection. Neurology, COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD):
Neuropsychiatry, Psychosomatics. 2022;14(Suppl 1):21–28. (In Russ.) A case report-based systematic review. Mult Scler Relat Disord.
DOI: 10.14412/2074-2711-2022.1S-21-28 2022;60:103697. DOI: 10.1016/j.msard.2022.103697

ОБ АВТОРАХ AUTHORS' INFO

Александра Олеговна Козлова, врач-невролог; Alexandra O. Kozlova, M.D., neurologist;
ORCID: https://orcid.org/0000-0002-2992-0199; ORCID: https://orcid.org/0000-0002-2992-0199;
e-mail: alykozlova96@gmail.com e-mail: alykozlova96@gmail.com
Альфия Ходжаевна Забирова, врач-невролог; Alfiia Kh. Zabirova, M.D., neurologist;
ORCID: https://orcid.org/0000-0001-8544-3107; ORCID: https://orcid.org/0000-0001-8544-3107;
e-mail: alfijasabirowa@gmail.com e-mail: alfijasabirowa@gmail.com
Екатерина Вадимовна Байдина, канд. мед. наук; Ekaterina V. Baydina, M.D., Ph.D. (Medicine);
ORCID: https://orcid.org/0000-0001-5911-5855; e-mail: baydina@ ORCID: https://orcid.org/0000-0001-5911-5855;
neurology.ru e-mail: baydina@neurology.ru
*Мария Николаевна Захарова, докт. мед. наук, профессор; *Mariya N. Zakharova, M.D., D.Sc. (Medicine), Professor;
адрес: Россия, 125367, г. Москва, Волоколамское шоссе, д. 80; address: 80, Volokolamskoye highway, Moscow, 125367, Russia;
ORCID: https://orcid.org/0000-0002-1072-9968; ORCID: https://orcid.org/0000-0002-1072-9968;
e-mail: zakharova@neurology.ru e-mail: zakharova@neurology.ru

* Автор, ответственный за переписку / Corresponding author
DOI: https://doi.org/10.17816/rmmar111889